2464.3000 -22.60 (-0.91%)
NSE Dec 26, 2025 15:31 PM
Volume: 32,764
 

2464.30
-0.91%
Sharekhan
Volume growth sustains; Low input cost and efficiencies led to margin expansion: GSK Consumer reported strong results in Q4FY2019, with broad-based growth across products and channels. Revenue grew by 9%, driven by 6.3% volume growth. Business auxiliary income rose by 20% y-o-y, led by double-digit growth across all products. Unlike other FMCG companies, GSK...
GlaxoSmithKline has lost -25.37% in the last 6 Months
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended